$EHTH
eHealth, Inc.

2017 Q1 Form 10-Q Financial Statement

#000133349317000065 Filed on May 05, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $41.56M $51.41M
YoY Change -19.17% -16.12%
Cost Of Revenue $181.0K $2.184M
YoY Change -91.71% -9.53%
Gross Profit $41.38M $49.23M
YoY Change -15.95% -16.39%
Gross Profit Margin 99.56% 95.75%
Selling, General & Admin $45.20M $47.70M
YoY Change -5.24% -14.97%
% of Gross Profit 109.24% 96.9%
Research & Development $8.072M $8.507M
YoY Change -5.11% -21.03%
% of Gross Profit 19.51% 17.28%
Depreciation & Amortization $762.0K $1.005M
YoY Change -24.18% -5.01%
% of Gross Profit 1.84% 2.04%
Operating Expenses $8.072M $8.507M
YoY Change -5.11% -21.03%
Operating Profit -$4.113M $3.149M
YoY Change -230.61% -256.51%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $277.0K -$11.00K
YoY Change -2618.18% -21.43%
Pretax Income -$3.836M $23.67M
YoY Change -116.2% -1268.41%
Income Tax -$4.916M $5.638M
% Of Pretax Income 23.82%
Net Earnings $1.080M -$795.0K
YoY Change -235.85% -61.82%
Net Earnings / Revenue 2.6% -1.55%
Basic Earnings Per Share $0.06 -$0.04
Diluted Earnings Per Share $0.06 -$0.04
COMMON SHARES
Basic Shares Outstanding 18.37M shares 18.15M shares
Diluted Shares Outstanding 18.56M shares 18.22M shares

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.20M $66.70M
YoY Change 2.25% 69.29%
Cash & Equivalents $68.23M $66.69M
Short-Term Investments
Other Short-Term Assets $4.500M $4.900M
YoY Change -8.16% -34.67%
Inventory
Prepaid Expenses
Receivables $27.90M $19.63M
Other Receivables $1.200M $17.90M
Total Short-Term Assets $100.6M $91.26M
YoY Change 10.21% 48.59%
LONG-TERM ASSETS
Property, Plant & Equipment $5.703M $6.733M
YoY Change -15.3% -24.72%
Goodwill $14.10M $14.10M
YoY Change 0.0% 0.0%
Intangibles $8.320M $9.360M
YoY Change -11.11% -10.25%
Long-Term Investments
YoY Change
Other Assets $4.416M $3.624M
YoY Change 21.85% -6.48%
Total Long-Term Assets $32.54M $33.81M
YoY Change -3.78% -9.46%
TOTAL ASSETS
Total Short-Term Assets $100.6M $91.26M
Total Long-Term Assets $32.54M $33.81M
Total Assets $133.1M $125.1M
YoY Change 6.43% 26.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.699M $2.057M
YoY Change -17.4% -10.68%
Accrued Expenses $11.10M $11.70M
YoY Change -5.13% 4.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.83M $24.19M
YoY Change -22.14% 26.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.400M $4.900M
YoY Change -71.43% -26.87%
Total Long-Term Liabilities $1.425M $4.888M
YoY Change -70.85% -26.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.83M $24.19M
Total Long-Term Liabilities $1.425M $4.888M
Total Liabilities $20.26M $29.07M
YoY Change -30.33% 12.71%
SHAREHOLDERS EQUITY
Retained Earnings $38.04M $27.53M
YoY Change 38.16% 126.06%
Common Stock $29.00K $29.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $200.0M $200.0M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $112.9M $96.00M
YoY Change
Total Liabilities & Shareholders Equity $133.1M $125.1M
YoY Change 6.43% 26.64%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $1.080M -$795.0K
YoY Change -235.85% -61.82%
Depreciation, Depletion And Amortization $762.0K $1.005M
YoY Change -24.18% -5.01%
Cash From Operating Activities $8.428M $4.697M
YoY Change 79.43% -142.04%
INVESTING ACTIVITIES
Capital Expenditures $862.0K $411.0K
YoY Change 109.73% 7.03%
Acquisitions $0.00
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.664M -$411.0K
YoY Change 304.87% 7.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$332.0K -$296.0K
YoY Change 12.16% -40.68%
NET CHANGE
Cash From Operating Activities $8.428M $4.697M
Cash From Investing Activities -$1.664M -$411.0K
Cash From Financing Activities -$332.0K -$296.0K
Net Change In Cash $6.432M $3.990M
YoY Change 61.2% -133.1%
FREE CASH FLOW
Cash From Operating Activities $8.428M $4.697M
Capital Expenditures $862.0K $411.0K
Free Cash Flow $7.566M $4.286M
YoY Change 76.53% -137.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001333493
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18431224 shares
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
eHealth, Inc.
CY2017Q1 dei Trading Symbol
TradingSymbol
EHTH
CY2016Q4 ehth Accrued Marketing Expenses
AccruedMarketingExpenses
7158000 USD
CY2017Q1 ehth Accrued Marketing Expenses
AccruedMarketingExpenses
3246000 USD
CY2016Q1 ehth Allocated Sharebased Compensation Expense Net Of Restructuring Reversal Expense
AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense
1832000 USD
CY2017Q1 ehth Allocated Sharebased Compensation Expense Net Of Restructuring Reversal Expense
AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense
2133000 USD
CY2016Q1 ehth Amortization Of Book Of Business Consideration
AmortizationOfBookOfBusinessConsideration
1597000 USD
CY2017Q1 ehth Amortization Of Book Of Business Consideration
AmortizationOfBookOfBusinessConsideration
1157000 USD
CY2016Q1 ehth Amortizationof Internally Developed Software
AmortizationofInternallyDevelopedSoftware
214000 USD
CY2017Q1 ehth Amortizationof Internally Developed Software
AmortizationofInternallyDevelopedSoftware
291000 USD
CY2016Q1 ehth Customer Care And Enrollment Expense
CustomerCareAndEnrollmentExpense
10400000 USD
CY2017Q1 ehth Customer Care And Enrollment Expense
CustomerCareAndEnrollmentExpense
12109000 USD
CY2016Q1 ehth Increase Decrease In Accrued Marketing Expenses
IncreaseDecreaseInAccruedMarketingExpenses
-7732000 USD
CY2017Q1 ehth Increase Decrease In Accrued Marketing Expenses
IncreaseDecreaseInAccruedMarketingExpenses
-3912000 USD
CY2016Q1 ehth Incremental Common Shares Attributable To Options
IncrementalCommonSharesAttributableToOptions
0 shares
CY2017Q1 ehth Incremental Common Shares Attributable To Options
IncrementalCommonSharesAttributableToOptions
33000 shares
CY2016Q1 ehth Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
64000 shares
CY2017Q1 ehth Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
158000 shares
CY2016Q1 ehth Other Revenue
OtherRevenue
4457000 USD
CY2017Q1 ehth Other Revenue
OtherRevenue
2757000 USD
CY2016Q1 ehth Technology And Content Expense
TechnologyAndContentExpense
8507000 USD
CY2017Q1 ehth Technology And Content Expense
TechnologyAndContentExpense
8072000 USD
CY2017Q1 ehth Treasury Stock Shares Outstanding Shares Acquired Previously Cancelled Vested Shares Withheld For Tax Purposes
TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes
499250 shares
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5112000 USD
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1699000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9213000 USD
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27902000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
176000 USD
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
182000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
272778000 USD
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
274611000 USD
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1832000 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2133000 USD
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
260000 USD
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
260000 USD
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1976000 shares
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1167000 shares
CY2016Q4 us-gaap Assets
Assets
108899000 USD
CY2017Q1 us-gaap Assets
Assets
133117000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
76142000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
100582000 USD
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
57715000 USD
CY2017Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
65436000 USD
CY2017Q1 us-gaap Depreciation
Depreciation
762000 USD
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.82
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.80
CY2016Q4 us-gaap Cash
Cash
4066000 USD
CY2017Q1 us-gaap Cash
Cash
2792000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62710000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66689000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61781000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68228000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3979000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6447000 USD
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
57715000 USD
CY2017Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
65436000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
29000 USD
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
29000 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18020000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33427000 USD
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
2184000 USD
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
1629000 USD
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
50161000 USD
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
47117000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
959000 USD
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
730000 USD
CY2016Q1 us-gaap Depreciation
Depreciation
1005000 USD
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-11000 USD
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
15000 USD
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.238
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.049
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10920000 USD
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7897000 USD
CY2016Q1 us-gaap Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards
EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
-276000 USD
CY2017Q1 us-gaap Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards
EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
-300000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7928000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9992000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
14096000 USD
CY2017Q1 us-gaap Goodwill
Goodwill
14096000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23672000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
31848000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5638000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1573000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1265000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3417000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9978000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18689000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-60000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-229000 USD
CY2016Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5835000 USD
CY2017Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3023000 USD
CY2016Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
6809000 USD
CY2017Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-374000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
153000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-107000 USD
CY2016Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
69387000 USD
CY2017Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
76182000 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8580000 USD
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8320000 USD
CY2016Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
57715000 USD
CY2017Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
65436000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
108899000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
133117000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27924000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
18831000 USD
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3374000 USD
CY2017Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1425000 USD
CY2016Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
20882000 USD
CY2017Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
15055000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-296000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-332000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-411000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1664000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4697000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8428000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
18034000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
33421000 USD
CY2016Q4 us-gaap Noncurrent Assets
NoncurrentAssets
32553000 USD
CY2017Q1 us-gaap Noncurrent Assets
NoncurrentAssets
32332000 USD
CY2017Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2017Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
50 state
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
23683000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
31822000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4473000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4416000 USD
CY2016Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3775000 USD
CY2017Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5259000 USD
CY2016Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
31000 USD
CY2017Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
59000 USD
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
411000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1664000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5148000 USD
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4452000 USD
CY2017Q1 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
200000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5608000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5703000 USD
CY2016Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
20000 USD
CY2017Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
32000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4616000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
38037000 USD
CY2016Q1 us-gaap Revenues
Revenues
73844000 USD
CY2017Q1 us-gaap Revenues
Revenues
78939000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1832000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2133000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
77601000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
112861000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
10663888 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
199998000 USD
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
199998000 USD
CY2017Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-1900000 USD
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18217000 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18561000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18153000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18370000 shares
CY2017Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Description of Business&#8212;</font><font style="font-family:inherit;font-size:10pt;">eHealth, Inc. (the &#8220;Company,&#8221; &#8220;eHealth,&#8221; &#8220;we&#8221; or &#8220;us&#8221;) is a leading private health insurance exchange for individuals, families and small businesses in the United States. Through our website addresses (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.eHealth.com</font><font style="font-family:inherit;font-size:10pt;">, &#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.eHealthInsurance.com</font><font style="font-family:inherit;font-size:10pt;">, &#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.eHealthMedicare.com, www.Medicare.com</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.PlanPrescriber.com)</font><font style="font-family:inherit;font-size:10pt;">, consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase Medicare-related, individual and family, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans. Our ecommerce technology also enables us to deliver consumers&#8217; health insurance applications electronically to health insurance carriers. We are licensed to market and sell health insurance in all </font><font style="font-family:inherit;font-size:10pt;">50</font><font style="font-family:inherit;font-size:10pt;"> states and the District of Columbia.&#160;</font></div></div>

Files In Submission

Name View Source Status
0001333493-17-000065-index-headers.html Edgar Link pending
0001333493-17-000065-index.html Edgar Link pending
0001333493-17-000065.txt Edgar Link pending
0001333493-17-000065-xbrl.zip Edgar Link pending
ehth-20170331.xml Edgar Link completed
ehth-20170331.xsd Edgar Link pending
ehth-20170331_cal.xml Edgar Link unprocessable
ehth-20170331_def.xml Edgar Link unprocessable
ehth-20170331_lab.xml Edgar Link unprocessable
ehth-20170331_pre.xml Edgar Link unprocessable
ehth03312017ex101.htm Edgar Link pending
ehth03312017ex311.htm Edgar Link pending
ehth03312017ex312.htm Edgar Link pending
ehth03312017ex321.htm Edgar Link pending
ehth03312017ex322.htm Edgar Link pending
ehth03312017form10-q.htm Edgar Link pending
exhibit102tomtsaoseparat.htm Edgar Link pending
exhibit102tomtsaoseparat001.jpg Edgar Link pending
exhibit102tomtsaoseparat002.jpg Edgar Link pending
exhibit102tomtsaoseparat003.jpg Edgar Link pending
exhibit102tomtsaoseparat004.jpg Edgar Link pending
exhibit102tomtsaoseparat005.jpg Edgar Link pending
exhibit102tomtsaoseparat006.jpg Edgar Link pending
exhibit102tomtsaoseparat007.jpg Edgar Link pending
exhibit102tomtsaoseparat008.jpg Edgar Link pending
exhibit102tomtsaoseparat009.jpg Edgar Link pending
exhibit102tomtsaoseparat010.jpg Edgar Link pending
exhibit102tomtsaoseparat011.jpg Edgar Link pending
exhibit102tomtsaoseparat012.jpg Edgar Link pending
exhibit102tomtsaoseparat013.jpg Edgar Link pending
exhibit102tomtsaoseparat014.jpg Edgar Link pending
exhibit102tomtsaoseparat015.jpg Edgar Link pending
exhibit102tomtsaoseparat016.jpg Edgar Link pending
exhibit102tomtsaoseparat017.jpg Edgar Link pending
exhibit102tomtsaoseparat018.jpg Edgar Link pending
exhibit102tomtsaoseparat019.jpg Edgar Link pending
exhibit102tomtsaoseparat020.jpg Edgar Link pending
exhibit102tomtsaoseparat021.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending